Hong Kong Food Stock News

HKBN (SEHK:1310) has just posted its H1 2026 scorecard, with trailing 12 month revenue of HK$11.4b and basic EPS of HK$0.14, setting the tone for how the year is shaping up after a period of faster earnings growth. The company has seen revenue move from HK$4,841.8m in H2 2024 to HK$5,734.3m in H1 2025 and HK$5,394.3m in H2 2025, while basic EPS shifted from HK$0.0067 to HK$0.0821 and HK$0.0685 across those same halves. This gives investors a clear line of sight on how the top and bottom line...

New Gonow Recreational Vehicles (SEHK:805) has released its FY 2025 numbers with first half revenue of C¥411.7 million and basic EPS of C¥0.0326, set against trailing twelve month revenue of C¥871.4 million and EPS of C¥0.03 that sit within a period of weaker earnings and a 3.5% net margin. Over recent reporting halves the company has seen revenue move between C¥421.97 million and C¥442.19 million, with basic EPS ranging from C¥0.0549 to C¥0.0028. Trailing earnings have been described as high...

From what we can see, insiders were net buyers in HG Semiconductor Limited's ( HKG:6908 ) during the past 12 months...

The market was pleased with the recent earnings report from Smoore International Holdings Limited ( HKG:6969 ), despite...

Li Ning Company Limited ( HKG:2331 ) shareholders are probably feeling a little disappointed, since its shares fell...

The market for CK Hutchison Holdings Limited's ( HKG:1 ) shares didn't move much after it posted weak earnings...

If you are wondering whether Genscript Biotech at HK$13.85 is priced for opportunity or already reflecting the story, this valuation breakdown is designed to give you a clear starting point. The stock has returned 0.7% over the last 7 days, 25.8% over the last 30 days, 8.3% year to date, and 25.2% over 1 year, while the 3 year and 5 year returns sit at 32.8% and 23.1% declines respectively. These mixed returns mean context really matters. Recent company updates, financing decisions,...

As global markets react positively to geopolitical de-escalations, the Asian market is experiencing a cautiously optimistic sentiment. This environment presents an intriguing backdrop for exploring penny stocks, which, despite their somewhat outdated label, continue to offer potential value through smaller or newer companies. By focusing on those with robust financials and clear growth trajectories, investors may find promising opportunities in these under-the-radar stocks that could offer...

As you might know, China Mobile Limited ( HKG:941 ) just kicked off its latest first-quarter results with some very...

Leapmotor (SEHK:9863) has introduced the D19, described as the world's first premium SUV using a centralized QNX based software platform. The system integrates the digital cockpit, advanced driver assistance, and connectivity functions into a single safety certified domain. This launch marks the first mass produced vehicle to consolidate these core software defined features on advanced QNX platforms. For investors watching the electric vehicle space, this move puts software architecture at...

Sinopharm Group (SEHK:1099) opened 2026 with Q1 revenue of about CNY 17.8b and basic EPS of CNY 0.52, setting the tone against a trailing twelve month profile that shows revenue of roughly CNY 574.7b and EPS of CNY 2.28. Over recent quarters investors have seen quarterly revenue move from about CNY 141.7b in Q1 2025 to CNY 145.4b in Q3 2025 and CNY 143.7b in Q4 2025, with basic EPS ranging from CNY 0.47 to CNY 3.29 across that period as the business cycled through different earnings levels...

If you are looking at Cathay Pacific Airways and asking whether the current share price fairly reflects its prospects, the valuation story is where things get interesting. The stock last closed at HK$11.96, with returns of 1.2% over 7 days, a 0.5% decline over 30 days, a 5.3% decline year to date, 43.4% over 1 year, 90.9% over 3 years and 108.7% over 5 years. This performance may lead you to question whether the current price still offers value or has already priced in much of the recent...

Genscript Biotech (SEHK:1548) has proposed amendments to its memorandum and articles of association. The planned changes relate to the company’s core corporate governance framework and could influence shareholder rights and internal decision making. For investors watching Genscript Biotech at a share price of HK$14.19, the move to adjust its foundational documents comes alongside mixed longer term share performance. The stock is up 6.6% over the past week, 33.9% over the past month, 10.9%...

Those following along with EVA Precision Industrial Holdings Limited ( HKG:838 ) will no doubt be intrigued by the...

The market seemed underwhelmed by last week's earnings announcement from S.A.S. Dragon Holdings Limited ( HKG:1184...

At its annual general meeting held on May 7, 2026, Ubtech Robotics Corp. Ltd. approved an H share repurchase that will cancel shares, reduce the company’s registered capital, and require amendments to its Articles of Association and related regulatory filings. This move is significant because it combines a capital structure change with formal bylaw revisions, prompting creditor notifications and potential bondholder meetings under applicable regulations. We’ll now examine how the approved H...

If you are wondering whether Akeso shares still offer value after a strong run, the numbers behind the current price deserve a closer look. At a last close of HK$149.30, Akeso has delivered returns of 1.3% over 7 days, 33.2% over 30 days, 31.8% year to date and 60.7% over 1 year, with a very large 3 year gain and 173.2% over 5 years. These moves have put Akeso on the radar of investors trying to understand what is already priced in and what may still be up for grabs. Recent coverage has...

Global markets have recently experienced a positive shift, with U.S. stocks achieving record highs and European indices showing strong performance, driven by easing geopolitical tensions and favorable economic data. In this context, penny stocks—often representing smaller or newer companies—continue to capture investor interest as they present unique opportunities for growth at lower price points. Despite the term 'penny stock' being somewhat outdated, these investments can still offer...

As global markets experience a positive shift with signs of de-escalation in the Middle East and strong earnings reports, investor sentiment is buoyed across major indices. In this context, penny stocks—often representing smaller or less-established companies—remain an intriguing investment area due to their potential for significant value growth. While the term may seem outdated, these stocks can offer opportunities for growth when backed by solid financials and a clear trajectory, making...

Investors signalled that they were pleased with The Wharf (Holdings) Limited's ( HKG:4 ) most recent earnings report...

Nongfu Spring Co., Ltd. ( HKG:9633 ) investors will be delighted, with the company turning in some strong numbers with...

As of April 2026, Asian markets are navigating a complex landscape shaped by geopolitical developments and mixed economic signals. Amidst this backdrop, the allure of penny stocks remains significant for investors seeking opportunities in smaller or newer companies that may offer value and growth potential. While the term "penny stocks" might seem outdated, these investments can still be relevant when backed by solid financials, offering a unique combination of affordability and potential...

If you are wondering whether Air China is priced attractively today, the focus here is on what the current share price might be telling you about its underlying value. The stock last closed at HK$5.23, with returns of 8.1% over the past week, 3.8% over the past month, 9.2% over the past year and a year-to-date decline of 26.4%, which may shape how you think about both opportunity and risk. Recent coverage around Air China has centred on its role in the broader airline sector, including how...

As Asian markets navigate a landscape marked by geopolitical tensions and economic fluctuations, investors are increasingly focused on identifying opportunities that may be undervalued relative to their intrinsic value. In this context, understanding the fundamentals of a company and its potential for growth is crucial for discerning stocks that might offer attractive valuations amidst broader market conditions.